JPMorgan Chase & Co. news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

JPM 68.56 -0.48 (-0.70%)
price chart
Is JPMorgan Chase & Co. Justified In Upgrading United States Steel Corporation?
In a report released on Thursday, JPMorgan Chase & Co. (NYSE:JPM) upgraded United States Steel Corporation (NYSE:X) stock from Neutral to Overweight.
United States Steel Upgraded to "Overweight" at JPMorgan Chase ...  The Legacy
AK Steel Holding Raised to Overweight at JPMorgan Chase & Co. (AKS)  Dakota Financial News
Shares of JP Morgan Chase & Co (NYSE:JPM) Sees Large Inflow of Net Money Flow
J P Morgan Chase & Co (NYSE:JPM) had a weak trading session and its shares were last down at $68.92, down -0.02% or -0.03 points.
Recent Investment Analysts' Ratings Updates for JPMorgan Chase & Co ...  Dakota Financial News
JPMorgan Chase & Co. Rating Reiterated by Deutsche Bank (JPM)  sleekmoney
JPMorgan Chase & Co. (JPM) Stock: Deutsche Bank Rates A Buy
JP Morgan Chase & Co. stock headed towards the positive territory in the pre-market trading hours today after Deutsche Bank's Markets Research updated the stock.
JPMorgan Chase & Co. Given "Buy" Rating at Deutsche Bank (JPM)  Dakota Financial News
J P Morgan Chase & Co (NYSE:JPM) Short Interest Update  Money Flow Index
Schroders plc's Overweight Rating Reiterated at JPMorgan Chase & Co. (SDR)
Schroders plc logo Schroders plc (LON:SDR)'s stock had its “overweight” rating restated by JPMorgan Chase & Co.
St. James's Place plc Rating Reiterated by JPMorgan Chase & Co. (STJ)  The Legacy
JPMorgan Chase & Co. Raises Ferrexpo Plc Price Target to GBX 70 (FXPO)  WKRB News
Acorda Therapeutics's Neutral Rating Reiterated at JPMorgan Chase & Co. (ACOR)
Acorda Therapeutics logo Acorda Therapeutics (NASDAQ:ACOR)'s stock had its “neutral” rating restated by analysts at JPMorgan Chase & Co. in a note issued to investors on Friday, Marketbeat.com reports. They presently have a $42.00 price objective on ...
Active Stocks Investor's Alert: Pfizer Inc. (NYSE:PFE), JPMorgan Chase & Co ...
Pfizer stated financial results for second-quarter 2015 and declared enhances to the midpoints of its 2015 financial guidance(3) ranges for stated revenues(1) and stated(1) and adjusted(2) diluted EPS.
Amgen Given Neutral Rating at JPMorgan Chase & Co. (AMGN)
Amgen logo Amgen (NASDAQ:AMGN)'s stock had its “neutral” rating reaffirmed by JPMorgan Chase & Co. in a note issued to investors on Friday, MarketBeat reports.
Southwest Airlines Upgraded to Overweight by JPMorgan Chase & Co. (LUV)
Southwest Airlines Co logo JPMorgan Chase & Co. upgraded shares of Southwest Airlines (NYSE:LUV) from a neutral rating to an overweight rating in a research report sent to investors on Thursday, TheFlyOnTheWall.
Southwest Airlines Raised to Overweight at JPMorgan Chase & Co. (LUV)  Dakota Financial News
JPMorgan Chase & Co. Reaffirms Overweight Rating for American Airlines Group (AAL)
American Airlines Group logo American Airlines Group (NASDAQ:AAL)'s stock had its “overweight” rating reissued by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, MarketBeat.com reports. They currently have a $72.00 ...
American Airlines Group Given Overweight Rating at JPMorgan Chase & Co ...  Mideast Time
United Continental Holdings Earns "Overweight" Rating from JPMorgan Chase & Co ...
United Continental Holdings logo United Continental Holdings (NYSE:UAL)'s stock had its “overweight” rating restated by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Thursday, MarketBeat reports. They presently ...
United Continental Holdings Receives "Overweight" Rating from ...  The Legacy